Nexgen Arrays Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $374K

  • Investors
  • 2

Nexgen Arrays General Information

Description

Developer of diagnostic technology platform designed for detecting Ebola viruses. The company's platform developed multiplexed virus detection tools for clinicians and point-of-care healthcare sites, enabling medical specialists to detect viral diseases such as Ebola, Lassa, and Marburg.

Contact Information

Website
nvdx-platform.launchrock.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 8 Saint Mary's Street
  • Boston, MA 02215
  • United States
+1 (617) 000-0000
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Other Healthcare Technology Systems
Vertical(s)
TMT, HealthTech
Corporate Office
  • 8 Saint Mary's Street
  • Boston, MA 02215
  • United States
+1 (617) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nexgen Arrays Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 01-Jan-2015 $374K Completed Startup
2. Grant 30-Sep-2014 0000 Completed Startup
1. Accelerator/Incubator 01-Jan-2014 Completed Startup
To view Nexgen Arrays’s complete valuation and funding history, request access »

Nexgen Arrays Executive Team (2)

Name Title Board Seat
George Daaboul Ph.D Co-Founder & Chief Scientific Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Nexgen Arrays Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nexgen Arrays Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institute for Allergy and Infectious Disease Government 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
To view Nexgen Arrays’s complete investors history, request access »

Ready to get started?

Request a free trial

Nexgen Arrays FAQs

  • When was Nexgen Arrays founded?

    Nexgen Arrays was founded in 2013.

  • Who is the founder of Nexgen Arrays?

    George Daaboul Ph.D and David Freedman Ph.D are the founders of Nexgen Arrays.

  • Where is Nexgen Arrays headquartered?

    Nexgen Arrays is headquartered in Boston, MA.

  • What is the size of Nexgen Arrays?

    Nexgen Arrays has 5 total employees.

  • What industry is Nexgen Arrays in?

    Nexgen Arrays’s primary industry is Diagnostic Equipment.

  • Is Nexgen Arrays a private or public company?

    Nexgen Arrays is a Private company.

  • What is Nexgen Arrays’s current revenue?

    The current revenue for Nexgen Arrays is 000000.

  • Who are Nexgen Arrays’s investors?

    National Institute for Allergy and Infectious Disease and National Science Foundation have invested in Nexgen Arrays.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »